Literature DB >> 11843719

Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection.

Birgit Winther1, Eurico Arruda, Theodore J Witek, Steven D Marlin, Michael M Tsianco, Donald J Innes, Frederick G Hayden.   

Abstract

Most rhinovirus serotypes use intercellular adhesion molecule-1 (ICAM-1) as the receptor to enter cells, but ICAM-1 expression has not been detected on normal nasal epithelial cells. During experimental rhinovirus infection, expression of ICAM-1 on nasal epithelial cells was examined with immunohistochemical staining of nasal scrape biopsy specimens, and levels of soluble ICAM-1 in nasal lavage fluid were measured by sandwich enzyme-linked immunosorbent assay technique. Expression of ICAM-1 on nasal epithelial cells increased following inoculation in 20 of 23 infected subjects. The median number of ICAM-1-positive cells per 6.25-mm(2) area of stained biopsy specimen was 0 in control samples (day 20 or 33 after inoculation), and in those without infection, 6 on day 1 (P< or =.05), 14.5 on day 3 (P< or =.01), 1.5 on day 5, and 0 on day 9. In a different group of volunteers, soluble ICAM-1 in nasal lavage fluid was higher on days 1 and 3 compared with preinoculation levels (P< or =.001), but only 11 of 23 infected subjects had a 2-fold or greater increase. Up-regulation of ICAM-1 receptor expression on nasal epithelial cells occurred within 24 hours after inoculation in experimental rhinovirus infections (prior to onset of symptoms) and declined promptly by day 5.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11843719     DOI: 10.1001/archotol.128.2.131

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  15 in total

Review 1.  Human rhinoviruses.

Authors:  Samantha E Jacobs; Daryl M Lamson; Kirsten St George; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

Review 2.  Rhinoviruses and Their Receptors: Implications for Allergic Disease.

Authors:  Yury A Bochkov; James E Gern
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

3.  Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.

Authors:  Jamil Jubrail; Kshanti Africano-Gomez; Floriane Herit; Anna Mularski; Pierre Bourdoncle; Lisa Oberg; Elisabeth Israelsson; Pierre-Regis Burgel; Gaell Mayer; Danen M Cunoosamy; Nisha Kurian; Florence Niedergang
Journal:  EMBO Rep       Date:  2019-11-13       Impact factor: 8.807

Review 4.  Rhinovirus and childhood asthma: an update.

Authors:  Dae Jin Song
Journal:  Korean J Pediatr       Date:  2016-11-18

5.  Respiratory DNA viruses are undetectable in nasopharyngeal secretions from adenotonsillectomized children.

Authors:  Ronaldo Bragança Martins; Lucas Penna Rocha; Mirela Moreira Prates; Talita Bianca Gagliardi; Balduino Biasoli; Marcelo Junqueira Leite; Guilherme Buzatto; Miguel Angelo Hyppolito; Davi Casale Aragon; Edwin Tamashiro; Fabiana Cardoso Pereira Valera; Eurico Arruda; Wilma Terezinha Anselmo-Lima
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

6.  Productive entry pathways of human rhinoviruses.

Authors:  Renate Fuchs; Dieter Blaas
Journal:  Adv Virol       Date:  2012-11-26

7.  IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM-1 release inhibits human rhinovirus infection.

Authors:  Suzanne C Whiteman; Monica A Spiteri
Journal:  J Inflamm (Lond)       Date:  2008-06-05       Impact factor: 4.981

Review 8.  Mechanism of human rhinovirus infections.

Authors:  Dieter Blaas; Renate Fuchs
Journal:  Mol Cell Pediatr       Date:  2016-06-01

Review 9.  Rhinoviruses and Respiratory Enteroviruses: Not as Simple as ABC.

Authors:  Léna Royston; Caroline Tapparel
Journal:  Viruses       Date:  2016-01-11       Impact factor: 5.048

10.  The effect of different workplace nanoparticles on the immune systems of employees.

Authors:  Natalja Kurjane; Tija Zvagule; Jelena Reste; Zanna Martinsone; Ilona Pavlovska; Inese Martinsone; Ivars Vanadzins
Journal:  J Nanopart Res       Date:  2017-09-13       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.